• Legend Biotech (NASDAQ:LEGN) Given "Overweight" Rating at Piper Sandler

    Source: Buzz FX / 30 Dec 2024 12:46:13   America/New_York


    Legend Biotech (NASDAQ:LEGN) Given "Overweight" Rating at Piper Sandler Written by MarketBeat December 30, 2024 Share Link copied to clipboard. Legend Biotech ( NASDAQ:LEGN - Get Free Report ) 's stock had its "overweight" rating restated b
    Read more...
Share on,